Narjust Florez, Assistant Professor of Medicine at Harvard Medical School, Co-Director Young Lung Cancer Program, Associate Director of the Cancer Access Program at Dana-Farber Cancer Institute, shared on X:
“Grateful to have contributed to this important collaborative study with Dr. Jaclyn LoPiccolo and an incredible research team.
Together, we explored the genetic factors that may shape risk and tumor biology in young-onset lung cancer.”
Title: Germline determinants of risk and molecular subtype in young-onset lung cancer
Authors: Jaclyn LoPiccolo, Ryan L Collins, Noah Fields, Carter Nakagawa, Kodi Taraszka, Xinan Wang, Li Su, Diane R Koeller, Alison Levine Schwartz, Alicia Charleston Pollaci, Sarah M Young, Victoria G Williamson, Jose A Avila, Emma Voligny, Tom Nguyen, Andy J Pangilinan, Richard M Erwin, Barbara J Gitlitz, Silvia Novello, Geoffrey R Oxnard, Ugonma N Chukwueke, Priscilla K Brastianos, Ayal A Aizer, Mizuki Nishino Hatabu, Narjust Florez, Kevin M Haigis, Eliezer M Van Allen, Jorge J Nieva, Judy E Garber, David C Christiani, Pasi A Jänne, Alexander Gusev
Read the Full Article.
Other posts featuring Narjust Florez on OncoDaily.
